Neuroprotective effect of carvedilol against aluminium induced toxicity: Possible behavioral and biochemical alterations in rats

Pharmacological Reports

Volumn 63, Issue 4, 2011, Pages 915-923

  Kumar, Anil ^a   Prakash, Atish ^a   Dogra, Samrita ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Aluminium; Alzheimer's disease; Carvedilol; Neuroprotection; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; CARVEDILOL; CATALASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; COGNITIVE DEFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXPLORATORY RESEARCH; LIPID PEROXIDATION; MALE; MAZE TEST; MENTAL PERFORMANCE; MENTAL TASK; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SHAM PROCEDURE; TREATMENT DURATION;

EID: 80053378855     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70607-7     Document Type: Article

References (40)

1. Abreu V, Santos L, Moreno M: Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J Pharmacol Exp Ther, 2000, 295, 1022-1030.
2. Becaria A, Campbell A, Bondy SC: Aluminum as a toxicant. Toxicol Ind Health, 2002, 18, 309-320. (Pubitemid 38352147)
3. Bharathi P, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, Rao KS: A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Brain Res Rev, 2006, 52, 275-292. (Pubitemid 44389686)
4. Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC: Chronic exposure to aluminium in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res, 2004, 75, 565-572. (Pubitemid 38160717)
5. Canales JJ, Corbalán R, Montoliu C, Llansola M, Monfort P, Erceg S, Hernandez-Viadel M, Felipo V: Aluminium impairs the glutamate-nitric oxide-cGMP pathway in cultured neurons and in rat brain in vivo: molecular mechanisms and implications for neuropathology. J Inorg Biochem, 2001, 87, 63-69.
6. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys, 1959, 82, 48670-48677.
7. Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 1961, 7, 88-95.
8. Feuerstein GZ, Shusterman NH, Ruffolo Jr RR: Carvedilol update IV: prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure. Drugs Today, 1997, 33, 453-457.
9. Garruto RM, Fukatsu R, Yanagihara R, Gajdusek DC, Hook G, Fiori CE: Imaging of calcium and aluminium in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci USA, 1984, 81, 1875-1879. (Pubitemid 14149568)
10. Germano C, Kinsella GJ: Working memory and learning in early Alzheimer's disease. Neuropsychol Rev, 2005, 15, 1-10. (Pubitemid 40576932)
11. Ghribi O, DeWitt DA, Forbes MS, Arad A, Herman MM, Savory J: Cyclosporin A inhibits Al-induced cytochrome c release from mitochondria in aged rabbits. J Alzheimers Dis, 2001, 3, 387-391. (Pubitemid 32843055)
12. Gornall AG, Bardawill CT, David MM: Determination of serum proteins by means of biuret reaction. J Biol Chem, 1949, 177, 751-766.
13. 15N]nitrate in biological fluids. Anal Biochem, 1982, 193, 265-275.
14. Gulya K, Rakonczay Z, Kasa P: Cholinotoxic effects of aluminium in rat brain. J Neurochem, 1990, 54, 1020-1026.
15. Habig WH, Jakoby WB: Assays for differentiation of glutathione-S- transferases. Methods Enzymol, 1981, 77, 398-405.
16. Kaizer RR, Corrȩa MC, Spanevello RM, Morsch VM, Mazzanti CM, Gonçalves JF, Schetinger MR: Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions. J Inorg Biochem, 2005, 99, 1865-1870. (Pubitemid 41253775)
17. Kawahara M, Muramoto K, Kobayashi K, Mori H, Kuroda Y: Aluminium promotes the aggregation of Alzheimer's β-amyloid protein in vitro. Biochem Biophys Res Commun, 1994, 198, 531-535. (Pubitemid 24178401)
18. Kono Y: Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys, 1978, 186, 189-195.
19. Kumar A, Dogra S: Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat. Pharmacol Biochem Behav, 2009, 92, 25-31.
20. Kumar A, Dogra S, Prakash A: Effect of carvedilol on behavioral, mitochondrial dysfunction, and oxidative damage against D-galactose induced senescence in mice. Naunyn Schmiedebergs Arch Pharmacol, 2009, 380, 431-441.
21. Kumar A, Dogra S, Prakash A: Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav Brain Res, 2009, 205, 384-390.
22. Kumar S: Biphasic effect of aluminium on cholinergic enzyme of rat brain. Neurosci Lett, 1998, 248, 121-123.
23. Luck H: Catalase. In: Methods of Enzymatic Analysis. Ed. Bergmeyer HU, Academic Press, New York, 1971, 885-893.
24. Lysko PG, Lysko KA, Yue TL, Webb CL, Gu JL, Feuerstein GZ: Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke, 1992, 23, 1630-1636.
25. Mačičkova T, Pečivova J, Nosal R, Holomanova D: Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2005, 149, 389-392.
26. McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL: Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology, 1996, 46, 401-405. (Pubitemid 26081321)
27. Miu AC, Benga O: Aluminium and Alzheimer's disease: a new look. J Alzheimers Dis, 2006, 10, 179-201. (Pubitemid 44767493)
28. Niu Q, Yang Y, Zhang Q, Niu P, He S, Di Gioacchino M, Conti P, Boscolo P: The relationship between Bcl-gene expression and learning and memory impairment in chronic aluminum-exposed rats. Neurotox Res, 2007, 12, 163-169.
29. Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs CJ: Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and parkinsonism- dementia of Guam. Science, 1982, 217, 1053-1055. (Pubitemid 12059105)
30. Platt B, Fiddler G, Riedel G, Henderson Z: Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull, 2001, 55, 257-267. (Pubitemid 32722168)
31. Prakash A, Kumar A: Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin Pharmacol Toxicol, 2009, 105, 98-104.
32. Provan SD, Yokel RA: Aluminium inhibits glutamate release from transverse rat hippocampal slices: role of G proteins, Ca channels and protein kinase C. Neurotoxicology, 1992, 13, 413-420.
33. Rabe A, Lee MH, Shek J, Wisniewski HM: Learning deficit in immature rabbits with aluminium-induced neurofibrillary changes. Exp Neurol, 1982, 76, 441-446. (Pubitemid 12112366)
34. Roskams AJ, Connor JR: Aluminium access to the brain: a role for transferrin and its receptors. Proc Natl Acad Sci USA, 1990, 87, 9024-9027. (Pubitemid 120007642)
35. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC: The novel β-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab, 2000, 20, 1197-1204. (Pubitemid 30636755)
36. Wills ED: Mechanism of lipid peroxide formation in animal tissues. Biochem J, 1966, 99, 667-676.
37. Yaoita H, Sakabe A, Maehara K, Maruyama Y: Differential effects of carvedilol, metoprolol and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation, 2002, 105, 975-980. (Pubitemid 34184577)
38. Yokel RA: The toxicology of aluminium in the brain: a review. Neurotoxicology, 2000, 21, 813-828.
39. Yoshioka T, Iwamoto N, Tsukahara F, Irie K, Urakawa I, Muraki T: Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells. Br J Pharmacol, 2000, 129, 1530-1535. (Pubitemid 30175728)
40. Zumkley H, Bertram HP, Lison A, Knoll O, Losse H: Al, Zn and Cu concentrations in plasma in chronic renal insufficiency. Clin Nephrol, 1979, 12, 18-21. (Pubitemid 9211845)